Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kaye L. Rathmann"'
Publikováno v:
Annals of Pharmacotherapy. 41:1499-1504
Alzheimer's disease is an insidious degenerative disease of the brain and is the leading cause of dementia in the U.S. Numerous etiologies have been postulated, including a large body of evidence suggesting a slow viral infection, possibly in genetic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d37b453c654398fcc40b4d8e2fabb433
https://doi.org/10.1345/aph.140065
https://doi.org/10.1345/aph.140065
Publikováno v:
The Annals of pharmacotherapy. 41(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e5567b47e43e0f4df3017479fe861a1c
https://pubmed.ncbi.nlm.nih.gov/17698893
https://pubmed.ncbi.nlm.nih.gov/17698893
Autor:
Larry K. Golightly, Cynthia J. R. Gelman, Barry H. Rumack, William J. Budwitz, Kaye L. Rathmann, Earl W. Sutherland, Anne G. Davis
Publikováno v:
American Journal of Health-System Pharmacy. 45:356-361
The methods of data collection, storage, and retrieval used by the Rocky Mountain Drug Consultation Center (RMDCC) are described. To substantiate that drug information services provided by RMDCC are clinically useful and have a beneficial effect on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8497b1f257c460565faa9cc35824841f
https://doi.org/10.1093/ajhp/45.2.356
https://doi.org/10.1093/ajhp/45.2.356
Autor:
Susan C. Smolinske, Earl W. Sutherland, Dennis R. Sawyer, Kaye L. Rathmann, John A. Sbarbaro, Cynthia J. R. Gelman, Christopher S. Conner
Publikováno v:
American Journal of Health-System Pharmacy. 39:849-851
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ca9043f34ba6c944b63912dc325bd67
https://doi.org/10.1093/ajhp/39.5.849
https://doi.org/10.1093/ajhp/39.5.849
Autor:
Larry K. Golightly, Kaye L. Rathmann
Publikováno v:
Drug intelligenceclinical pharmacy. 18(12)
Chelation therapy with intravenous injections of edetate disodium is being promoted to the public as a nonsurgical means to treat coronary or other arterial atherosclerosis. The rationale for use, clinical efficacy, and safety are reviewed. Acceptabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cda9216d9137a495f8cc0c44321d257
https://pubmed.ncbi.nlm.nih.gov/6439540
https://pubmed.ncbi.nlm.nih.gov/6439540
Publikováno v:
Drug Intelligence & Clinical Pharmacy. 22:510-511
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::127cc0d4c3ccf18fe609de2d12c8abc4
https://doi.org/10.1177/106002808802200624
https://doi.org/10.1177/106002808802200624